---
schema_version: "secwatch.filing_event.v1"
accession: "0001609550-24-000032"
form_type: "8-K"
ticker: "INSP"
cik: "0001609550"
company_name: "Inspire Medical Systems, Inc."
filed_at: "2024-07-22T23:59:59+00:00"
generated_at: "2026-05-31T18:32:59.069551+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Inspire Medical COO Philip Ebeling resigns effective Aug 9 to become CEO at private cardiology device firm

## Summary
- Philip J. Ebeling notified Inspire Medical on July 18, 2024 of his resignation as COO, effective Aug 9, 2024.
- Ebeling leaves to become President and CEO of a private medical device company in the cardiology space.
- Resignation was not due to any disagreement with the Company or its management.
- Ebeling joined Inspire Medical in June 2020; the Company will conduct a search for a new COO with an executive search firm.

## SEC filing metadata
- accession: 0001609550-24-000032
- form_type: 8-K
- ticker: INSP
- cik: 0001609550
- company_name: Inspire Medical Systems, Inc.
- filed_at: 2024-07-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1609550/000160955024000032/0001609550-24-000032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1609550/000160955024000032/insp-20240718.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001609550-24-000032
- JSON: https://secwatch.observer/filing/0001609550-24-000032.json
- Plain text: https://secwatch.observer/filing/0001609550-24-000032.txt

## Key facts
- Executive change
  Philip J. Ebeling resigned as Chief Operating Officer at Inspire Medical Systems, Inc..
  - Action: resigned
  - Role: Chief Operating Officer
  source text: On July 18, 2024, Philip J. Ebeling notified Inspire Medical Systems, Inc. (the “ Company ”) of his decision to resign as Chief Operating Officer of the Company, effective as of August 9, 2024, in order to pursue a new professional opportunity as President and Chief Executive Officer of a private medical device company operating in the cardiology space.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1609550/000160955024000032/0001609550-24-000032-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.